David A. Siegel Sensus Healthcare, Inc. Transaction History
Two Sigma Advisers, LP
- $42.8 Billion
- Q1 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 12,200 shares of SRTS stock, worth $58,926. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,200
Previous 10,800
12.96%
Holding current value
$58,926
Previous $73,000
21.92%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SRTS
# of Institutions
58Shares Held
4.04MCall Options Held
16.6KPut Options Held
23.3K-
Vanguard Group Inc Valley Forge, PA740KShares$3.57 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX542KShares$2.62 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA471KShares$2.27 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny260KShares$1.25 Million0.0% of portfolio
-
Morgan Stanley New York, NY195KShares$943,3180.0% of portfolio
About Sensus Healthcare, Inc.
- Ticker SRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,556,000
- Market Cap $80M
- Description
- Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...